期刊文献+

血栓性血小板减少性紫癜血浆置换治疗临床护理探讨 被引量:5

血栓性血小板减少性紫癜血浆置换治疗临床护理探讨
下载PDF
导出
摘要 目的探讨血栓性血小板减少性紫癜患者行血浆置换治疗的护理措施、安全性及其效果。方法回顾性分析近6年来行血浆置换治疗的21例血栓性血小板减少性紫癜患者各项临床资料,以探讨其合理、科学的护理措施。结果经血浆置换治疗及相应护理,本组21例血栓性血小板减少性紫癜患者有19例痊愈出院、1例复发、1例因颅内出血死亡。结论科学、合理、细致的护理措施配合血浆置换治疗,能有效降低血栓性血小板减少性紫癜患者的病死率,促进患者预后康复。 Objective Explore thrombotic thrombocytopenic purpura patients were done plasma exchange nursing measures,safety and its effect.Methods For nearly six years the retrospective analysis our plasma exchange line 21 cases of thrombotic thrombocytopenic purpura the clinical data of patients,in order to discuss the reasonable and scientific nursing measures.Results The plasma exchange and the corresponding nursing,this group of 21 cases of thrombotic thrombocytopenic purpura patients have 19 cases,1 patient was discharged patients recurred,1 cases of intracranial bleeding death.Conclusion The scientific,reasonable and meticulous nursing measures with plasma treatment,can effectively reduce the thrombotic thrombocytopenic purpura the mortality of patients,and promote the prognosis of patients with recovery.
作者 朱德霞
出处 《当代医学》 2012年第35期2-3,共2页 Contemporary Medicine
关键词 血栓性血小板减少性紫癜 血浆置换 护理 效果 Thrombotic thrombocytopenic purpura Plasma exchange Nursing Effect
  • 相关文献

参考文献7

二级参考文献18

  • 1刘芳,金洁,董宁征,王云贵,阮长耿.一例两种新的ADAMTS13基因突变导致的遗传性血栓性血小板减少性紫癜[J].中华血液学杂志,2005,26(9):521-524. 被引量:11
  • 2刘冬妍,李航,李学旺.血浆置换在危重症疾病治疗中的应用进展[J].国际移植与血液净化杂志,2006,4(1):1-4. 被引量:13
  • 3兰天飙,杨晓,孙世澜.血浆置换疗法的临床应用[J].内科急危重症杂志,2006,12(1):33-36. 被引量:17
  • 4Furlan M,Robles R,Lamie B.Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.Blood,1996,87:4223-4234.
  • 5Tsai HM.Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.Blood,1996,87:4235-4244.
  • 6Zheng X,Chung D,Takayama TK,et al.Structure of von Willebrand factor-cleaving protease (ADAMTS13),a metalloprotease involved in thrombotic thrombocytopenic purpura.J Biol Chem,2001,276:41059-41063.
  • 7Fujikawa K,Suzuki H,McMullen B,et al.Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family.Blood ,2001,98:1662-1666.
  • 8Rick ME,Molls S,Taylor MA.Clinical use of a rapid collagen binding assay for yon Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura.Thromb Haemost,2002,88:598-604.
  • 9Furlan M,Robles R,Solenthaler M ,et al.Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.Blood,1998,91:2839-2846.
  • 10Tsai HM,Lian EC.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med,1998,339:1585-1594.

共引文献33

同被引文献20

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部